Qureight
healthtech · AI imaging · clinical trials
Qureight raises $20M Series B to scale AI lung and heart imaging trials
July 29, 2026$20M · Series B
Turning CT scans into quantitative biomarkers lets trial sponsors measure fibrosis progression faster than radiologists reading scans by eye.
Lead Investors
Molten Ventures
Read the Full Story in Velocity
Get curated startup and tech news with new stories published daily, company insights, and real-time alerts.